Roche's Sabry retires; Duchenne drug fails confirmatory test
BioPharma
Stay updated with breaking news from James Sabry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Basel, 27 May 2024 - Roche announced today that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head...
Basel, 27 May 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that James Sabry (1958), Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry
Roche announced that James Sabry , Head of Roche Pharma Partnering, will be retiring after fourteen years with the company. James Sabry joined Genentech in 2010 as Head of Genentech Partnering. In...
The world's biggest drugmakers are racing to buy up biotech companies to fill looming holes in their pipelines and pounce on new discoveries, bringing a hopeful buzz back to JPMorgan Chase & Co.'s big health-care conference in San Francisco.